Metraipolis › archive › dc_6529bc4c476d

Impact of nirsevimab universal prophylaxis on RSV bronchiolitis hospitalizations. A tertiary level children's hospital perspective — Europe PMC PMID:41798280

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41798280
DOI
10.3389/fped.2026.1676689
License (as archived)
solo-consultazione
Archived
2026-11-05T15:27:23.587Z
SHA-256 of the archived text
cb2353cc946d8ae983786f3d3c9eb8abad9db6b0c85516af6dabde59d2c2de9d
Stable URL of this page
https://metraipolis.com/documento/dc_6529bc4c476d

How to cite

Impact of nirsevimab universal prophylaxis on RSV bronchiolitis hospitalizations. A tertiary level children's hospital perspective — Europe PMC PMID:41798280 — Europe PMC (en), https://europepmc.org/article/MED/41798280 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6529bc4c476d (Metraipolis archive dc_6529bc4c476d, sha256 cb2353cc946d8ae983786f3d3c9eb8abad9db6b0c85516af6dabde59d2c2de9d)
BibTeX
@misc{dc6529bc4c476d,
  title = {Impact of nirsevimab universal prophylaxis on RSV bronchiolitis hospitalizations. A tertiary level children's hospital perspective — Europe PMC PMID:41798280},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41798280},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6529bc4c476d; sha256 cb2353cc946d8ae983786f3d3c9eb8abad9db6b0c85516af6dabde59d2c2de9d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41798280. Agents can read the archived copy with the MCP tool read_document.